omniture
logo
Search
昱展新藥生技 ALAR PHARMACEUTICALS INC
Media Room

Latest News

rss

Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000

* Single-ascending-dose (SAD) study successfully demonstrated the safety, tolerability, and susta...

2022-01-13 00:00 1922

Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients

* ALA-1000 is the first, three-month slow-release Buprenorphine injection. * Initial results sho...

2021-03-10 00:00 1403